Alnylam Retains Key Claims for Kinesin Spindle Protein (KSP) RNAi Patent in Interference Proceedings – MSN Money
The next phase of the interference proceedings will examine the respective priority date for each of the parties’ claims consistent with current U.S. patent law’s “first to invent” statute. “The maintained claims in the KSP RNAi patent ...
Subscribe to LegalLaw247.Com Newsletter
